HGH Fragment 176-191
Investigación moderadaGrowth Hormone Fragment | Fat Loss Peptide
HGH Fragment 176-191 is the fat-burning segment of human growth hormone, corresponding to amino acids 176 through 191 of the full GH molecule.
Datos moleculares y de investigación
- Secuencia
- Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe
- Peso molecular
- 1,817.1 Da
- Vida media
- 15-20 minutes
- Rutas (investigación)
- injectable
- Almacenamiento
- Lyophilized: room temp or freezer long-term. Reconstituted: 2-8 degrees C for 28 days
Overview
HGH Fragment 176-191 is the fat-burning segment of human growth hormone, corresponding to amino acids 176 through 191 of the full GH molecule. It stimulates lipolysis and inhibits lipogenesis without the growth-promoting or insulin-disrupting effects associated with full-length HGH. AOD-9604 is a modified version of this fragment with an added N-terminal tyrosine residue.
Mechanism of action
Mimics the lipolytic region of human growth hormone by stimulating fat breakdown through beta-3 adrenergic receptor pathways. Unlike full HGH, it does not bind the growth hormone receptor, so it does not increase IGF-1 levels or interfere with glucose metabolism. The fragment selectively targets adipose tissue to promote fat oxidation.
Key research findings
- Stimulates lipolysis without growth hormone side effects
- Does not affect blood glucose or insulin sensitivity
- Does not increase IGF-1 levels
- Selectively targets fat metabolism
- No impact on bone or organ growth
Research applications
Fat Loss
- Lipolysis Enhancement — Increases fat oxidation and breakdown of stored triglycerides in adipose tissue without affecting glucose homeostasis.
- Lipogenesis Inhibition — Reduces new fat synthesis and storage, complementing the lipolytic action for overall fat reduction.
- Body Composition — Promotes selective fat loss while preserving lean mass, particularly effective when combined with a caloric deficit and exercise.
Preguntas frecuentes sobre HGH Fragment 176-191
Is HGH Fragment 176-191 safe to use with insulin?+
HGH Frag 176-191 does not affect blood glucose or insulin sensitivity directly, unlike full-length HGH. However, you should still monitor blood glucose if combining with insulin due to the fragment's lipolytic effects and the potential for unpredictable metabolic changes.
Can I combine HGH Fragment 176-191 with full-length HGH?+
Not recommended. HGH already contains the 176-191 sequence, so adding the fragment provides redundant lipolytic action while increasing HGH-related side effects without proportional fat-loss benefit. Choose one or the other.
How quickly will I see fat loss from HGH Fragment 176-191?+
Fat loss typically becomes noticeable around week 3-4 with proper diet and exercise. Weeks 5-8 show more significant reduction. Most users run 8-12 week cycles, with continued benefits observable through week 12.
Do I need to fast before injecting HGH Fragment 176-191?+
Yes. Fasting is important for optimal effect. Inject on an empty stomach and wait at least 30 minutes before eating. Elevated insulin from food intake can suppress the lipolytic signaling that makes this fragment effective.
References
- [1]Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragmentInternational Journal of Obesity
- [2]The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out miceEndocrinology
- [3]Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormoneHormone Research
- [4]Effects of oral administration of a synthetic fragment of human growth hormone on lipid metabolismAmerican Journal of Physiology - Endocrinology and Metabolism
- [5]Detection and in vitro metabolism of AOD9604Drug Testing and Analysis
Péptidos relacionados
5-Amino-1MQ
PreclinicalNNMT Inhibitor | Longevity & Metabolic Enhancement
5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function.
AOD-9604
Well studiedModified hGH Fragment | Fat Loss Peptide
AOD-9604 is a modified fragment of human growth hormone (amino acids 176-191) that stimulates lipolysis and inhibits lipogenesis without the side effects of full growth hormone.
BAM-15
Moderate researchMitochondrial Uncoupler | Metabolic Enhancer
BAM-15 is a synthetic mitochondrial uncoupler that has emerged as a promising research compound for obesity and metabolic disorders.
Cagrilintide
Extensively studiedLong-Acting Amylin Receptor Agonist | Weight Loss & Diabetes
Novel long-acting lipidated amylin analog functioning as dual amylin and calcitonin receptor agonist for weight management and type 2 diabetes.